federal_register: 2020-26037
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts | regulation_id_numbers |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020-26037 | Most Favored Nation (MFN) Model | Rule | This interim final rule with comment period (IFC) implements the Most Favored Nation (MFN) Model, a new Medicare payment model under section 1115A of the Social Security Act (the Act). The MFN Model will test whether more closely aligning payment for Medicare Part B drugs and biologicals (hereafter, referred to as "drugs") with international prices and removing incentives to use higher-cost drugs can control unsustainable growth in Medicare Part B spending without adversely affecting quality of care for beneficiaries. | 2020-11-27 | 2020 | 11 | https://www.federalregister.gov/documents/2020/11/27/2020-26037/most-favored-nation-mfn-model | https://www.govinfo.gov/content/pkg/FR-2020-11-27/pdf/2020-26037.pdf | Health and Human Services Department; Centers for Medicare & Medicaid Services | 221,45 | This interim final rule with comment period (IFC) implements the Most Favored Nation (MFN) Model, a new Medicare payment model under section 1115A of the Social Security Act (the Act). The MFN Model will test whether more closely aligning payment for... |